Dr. Tang is a longtime veteran of the medical diagnostic industry. He led OraSure Technologies, Inc. (NASDAQ: OSUR), a pioneer and global leader in rapid at-home tests for HIV and COVID-19, for ten years as president and CEO, chairman of the board of directors, and chairman of the compensation committee. During his tenure as president and CEO, OraSure launched more FDA-cleared products, vastly expanded its sales, and developed and acquired more innovative products and services in its history.
Prior to leading OraSure, Dr. Tang was president and CEO of the University City Science Center in Philadelphia, the mid-Atlantic region’s premier innovation hub for life science companies. He also led Olympus America’s Life Sciences Group, which included laboratory diagnostic, microscope, and translational research instruments. He earned his BS in Chemistry from the College of William & Mary, MS and Ph.D. in Chemical Engineering from Lehigh University, and an MBA for Executives from The Wharton School of Business at the University of Pennsylvania. In 2016, he was awarded a Doctor of Humane Letters (honoris causa) from Thomas Jefferson University (formerly Philadelphia University) and the Wagner Free Institute of Science.
